Loading clinical trials...
Loading clinical trials...
Conditions
Locations
1
United States
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Start Date
July 3, 2014
Primary Completion Date
December 1, 2026
Completion Date
December 1, 2026
Last Updated
April 27, 2026
NCT06043817
NCT07177937
NCT02621021
NCT03050268
NCT07363252
NCT05969860
Lead Sponsor
Dana-Farber Cancer Institute
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions